dexamfetamine (ANP Therapeutics)

N/A

Report date: 2025/12/26 17:54:00
NME

Base Information

Drug Namedexamfetamine (ANP Therapeutics)
Drug Alias Namedextroamphetamine (ANP Therapeutics)dexamfetaminedextroamphetamineANP-012
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCocaine-Related DisordersSubstance-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesANP Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesANP Therapeutics
Active IndicationsN/A
Inactive IndicationsCocaine-Related DisordersSubstance-Related Disorders

Other Information

ATC CodeN/A
Related LinksWikipedia